# Chiron Real Estate Inc.: financial statements, quarterly

XRN · NYSE · CIK 1533615 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xrn.md) · [Financials](/companies/xrn/financials.md) · [Filings](/companies/xrn/filings.md) · [Insiders](/companies/xrn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xrn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [35.5](/filings/0001558370-24-014861.md) | [33.0 d](/filings/0001104659-26-021956.md) | [35.1](/filings/0001558370-25-006963.md) | [34.2](/filings/0001558370-25-010515.md) | [34.3](/filings/0001104659-25-106984.md) | [35.2 d](/filings/0001104659-26-021956.md) | [34.6](/filings/0001104659-26-057206.md) | [38.0](/filings/0001104659-26-093347.md) | [37.2](/filings/0001104659-25-106984.md) | [38.4 d](/filings/0001104659-26-021956.md) | [38.1](/filings/0001104659-26-057206.md) | [39.7](/filings/0001104659-26-093347.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [29.8](/filings/0001104659-26-093347.md) | not reported | not reported | not reported | [29.7](/filings/0001104659-26-093347.md) |
| Interest expense | $m | [7.2](/filings/0001558370-23-017988.md) | [7.0 d](/filings/0001558370-24-002000.md) | [6.9](/filings/0001544784-24-000041.md) | [7.0](/filings/0001558370-25-010515.md) | [7.2](/filings/0001104659-25-106984.md) | [7.6 d](/filings/0001104659-26-021956.md) | [7.2](/filings/0001104659-26-057206.md) | [8.0](/filings/0001104659-26-093347.md) | [8.2](/filings/0001104659-25-106984.md) | [8.4 d](/filings/0001104659-26-021956.md) | [7.2](/filings/0001104659-26-057206.md) | [8.8](/filings/0001104659-26-093347.md) |
| Net income | $m | [4.8](/filings/0001558370-24-014861.md) | [0.6 d](/filings/0001104659-26-021956.md) | [2.3](/filings/0001558370-25-006963.md) | [(2.0)](/filings/0001558370-25-010515.md) | [3.4](/filings/0001104659-25-106984.md) | [2.9 d](/filings/0001104659-26-021956.md) | [3.7](/filings/0001104659-26-057206.md) | [0.6](/filings/0001104659-26-093347.md) | [(5.1)](/filings/0001104659-25-106984.md) | [(6.1) d](/filings/0001104659-26-021956.md) | [1.7](/filings/0001104659-26-057206.md) | [72.3](/filings/0001104659-26-093347.md) |
| Diluted EPS | $ per share | [0.05](/filings/0001558370-24-014861.md) | not reported | [0.01](/filings/0001558370-25-006963.md) | [(0.05)](/filings/0001558370-25-010515.md) | [0.14](/filings/0001104659-25-106984.md) | not reported | [0.16](/filings/0001104659-26-057206.md) | [(0.06)](/filings/0001104659-26-093347.md) | [(0.45)](/filings/0001104659-25-106984.md) | not reported | [(0.06)](/filings/0001104659-26-057206.md) | [4.78](/filings/0001104659-26-093347.md) |
| Basic EPS | $ per share | [0.05](/filings/0001558370-24-014861.md) | not reported | [0.01](/filings/0001558370-25-006963.md) | [(0.05)](/filings/0001558370-25-010515.md) | [0.14](/filings/0001104659-25-106984.md) | not reported | [0.16](/filings/0001104659-26-057206.md) | [(0.06)](/filings/0001104659-26-093347.md) | [(0.45)](/filings/0001104659-25-106984.md) | not reported | [(0.06)](/filings/0001104659-26-057206.md) | [4.78](/filings/0001104659-26-093347.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.3](/filings/0001558370-24-014861.md) | [1.3](/filings/0001558370-25-001938.md) | [1.3](/filings/0001558370-25-006963.md) | [5.0](/filings/0001558370-25-010515.md) | [5.7](/filings/0001104659-25-106984.md) | [6.8](/filings/0001104659-26-021956.md) | [5.4](/filings/0001104659-26-057206.md) | [6.6](/filings/0001104659-26-093347.md) | [7.1](/filings/0001104659-25-106984.md) | [9.1](/filings/0001104659-26-093347.md) | [8.2](/filings/0001104659-26-057206.md) | [10.7](/filings/0001104659-26-093347.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,303](/filings/0001558370-23-017988.md) | [1,268](/filings/0001558370-25-001938.md) | [1,264](/filings/0001544784-24-000041.md) | [1,241](/filings/0001558370-24-011347.md) | [1,243](/filings/0001558370-24-014861.md) | [1,256](/filings/0001104659-26-021956.md) | [1,270](/filings/0001558370-25-006963.md) | [1,297](/filings/0001558370-25-010515.md) | [1,273](/filings/0001104659-25-106984.md) | [1,242](/filings/0001104659-26-093347.md) | [1,238](/filings/0001104659-26-057206.md) | [1,372](/filings/0001104659-26-093347.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [669](/filings/0001558370-23-017988.md) | [662](/filings/0001558370-25-001938.md) | [666](/filings/0001544784-24-000041.md) | [663](/filings/0001558370-24-011347.md) | [678](/filings/0001558370-24-014861.md) | [701](/filings/0001104659-26-021956.md) | [731](/filings/0001558370-25-006963.md) | [772](/filings/0001558370-25-010515.md) | [767](/filings/0001104659-25-106984.md) | [712](/filings/0001104659-26-093347.md) | [717](/filings/0001104659-26-057206.md) | [688](/filings/0001104659-26-093347.md) |
| Long-term debt | $m | not reported | not reported | [25.7](/filings/0001544784-24-000041.md) | [14.7](/filings/0001558370-24-011347.md) | [14.5](/filings/0001558370-24-014861.md) | [14.4](/filings/0001558370-25-001938.md) | [14.3](/filings/0001558370-25-006963.md) | [14.2](/filings/0001558370-25-010515.md) | [1.2](/filings/0001104659-25-106984.md) | [1.2](/filings/0001104659-26-021956.md) | not reported | not reported |
| Shareholders' equity | $m | [611](/filings/0001558370-23-017988.md) | [584](/filings/0001558370-25-001938.md) | [575](/filings/0001544784-24-000041.md) | [556](/filings/0001558370-24-011347.md) | [543](/filings/0001558370-24-014861.md) | [534](/filings/0001104659-26-021956.md) | [517](/filings/0001558370-25-006963.md) | [503](/filings/0001558370-25-010515.md) | [485](/filings/0001104659-25-106984.md) | [510](/filings/0001104659-26-093347.md) | [500](/filings/0001104659-26-057206.md) | [657](/filings/0001104659-26-093347.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.7 d](/filings/0001558370-24-014861.md) | [18.1 d](/filings/0001104659-26-021956.md) | [14.3](/filings/0001558370-25-006963.md) | [18.9 d](/filings/0001558370-25-010515.md) | [16.3 d](/filings/0001104659-25-106984.md) | [20.5 d](/filings/0001104659-26-021956.md) | [12.3](/filings/0001104659-26-057206.md) | [22.1 d](/filings/0001104659-26-093347.md) | [17.6 d](/filings/0001104659-25-106984.md) | [21.6 d](/filings/0001104659-26-021956.md) | [13.4](/filings/0001104659-26-057206.md) | [22.6 d](/filings/0001104659-26-093347.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [1.5 d](/filings/0001558370-24-014861.md) | [1.5 d](/filings/0001104659-26-021956.md) | [1.5](/filings/0001558370-25-006963.md) | [1.5 d](/filings/0001558370-25-010515.md) | [1.5 d](/filings/0001104659-25-106984.md) | [1.5 d](/filings/0001104659-26-021956.md) | [15.3](/filings/0001104659-26-057206.md) | [15.2 d](/filings/0001104659-26-093347.md) | [(26.1) d](/filings/0001104659-25-106984.md) | [1.5 d](/filings/0001104659-26-021956.md) | [10.9](/filings/0001104659-26-057206.md) | [10.9 d](/filings/0001104659-26-093347.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.5](/filings/0001558370-23-017988.md) | [65.5](/filings/0001544784-24-000041.md) | [65.5](/filings/0001558370-24-011347.md) | [65.6](/filings/0001558370-24-014861.md) | [65.6](/filings/0001558370-25-006963.md) | [65.6](/filings/0001558370-25-010515.md) | [13.1](/filings/0001104659-25-106984.md) | [13.4](/filings/0001104659-26-057206.md) | [13.4](/filings/0001104659-26-093347.md) | [13.4](/filings/0001104659-25-106984.md) | [13.2](/filings/0001104659-26-057206.md) | [13.2](/filings/0001104659-26-093347.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,237,830 at 2026-08-03, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093347.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.